ArticleBMC public health2022

COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia.

Anton Barchuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.